Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia

By Walenga J.M.   Ahmad S.   Hoppensteadt D.   Iqbal O.   Hursting M.J.   Lewis B.E.  

Thrombosis Research, Vol. 105, Iss. 5, 2002-03 ,pp. : 401-405

Elsevier

Access to resources Recommend Favorite

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect

By Nakagawa Tetsuya  

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 277-277

Oxford University Press

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 2, 2005-10 ,pp. : 137-137

Springer Publishing Company

Access to resources Recommend Favorite

Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban

By Warkentin T.E.  

Thrombosis Research, Vol. 110, Iss. 2, 2003-05 ,pp. : 73-82

Elsevier

Access to resources Recommend Favorite